Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Oct;87(1):297-303.
doi: 10.1083/jcb.87.1.297.

Ca2+-dependent recycling of synaptic vesicles at the frog neuromuscular junction

Ca2+-dependent recycling of synaptic vesicles at the frog neuromuscular junction

B Ceccarelli et al. J Cell Biol. 1980 Oct.

Abstract

Frog cutaneous pectoris muscles were treated with low doses of crude black widow spider venom (BWSV) or purified alpha-latrotoxin, and neuromuscular transmission, quantal secretion, changes in ultrastructure and uptake of horseradish peroxidase (HRP) were studied. When these agents were applied to muscles bathed in a Ca2+-free solution with 1 mM EGTA and 4 mM Mg2+, the rate of quantal secretion rose to high levels but quickly subsided; neuromuscular transmission was totally and irreversibly blocked within 1 h. The terminals became swollen and were depleted of vesicles; HRP was not taken up. When BWSV was applied to other muscles bathed in a solution with 1.8 mM Ca2+ and 4 mM Mg2+, the rate of secretion rose to high levels and then declined to intermediate levels that were sustained throughot the hour of exposure. Neuromuscular transmission was blocked in fewer than 50% of these fibers. The ultrastructure of these terminals was normal and they contained large numbers of synaptic vesicles. If HRP had been present, most of the synaptic vesicles were labeled with reaction product. These observations suggest that Ca2+ plays an important role in endocytosis at the frog neuromuscular junction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Rev. 1970 Sep;22(3):389-428 - PubMed
    1. J Cell Biol. 1972 Jul;54(1):30-8 - PubMed
    1. J Cell Biol. 1973 May;57(2):315-44 - PubMed
    1. J Cell Biol. 1973 May;57(2):499-524 - PubMed
    1. Adv Cytopharmacol. 1974;2:141-54 - PubMed

Publication types